VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: Inverse correlation between expression in tumor and stromal cells

被引:25
作者
Donnem, Tom [1 ]
Al-Shibli, Khalid [2 ,3 ]
Al-Saad, Samer [2 ]
Delghandi, Marit P.
Busund, Lill-Tove [2 ]
Bremnes, Roy M.
机构
[1] Univ Tromso, Inst Clin Med, Dept Oncol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway
[3] Nordland Cent Hosp, Dept Pathol, Bodo, Norway
关键词
NSCLC; Lymphangiogenesis; VEGFs; VEGFRs; Tumor-stroma interaction; ENDOTHELIAL GROWTH-FACTOR; CLINICAL-SIGNIFICANCE; FACTOR-C; PERITUMORAL LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; PROGNOSTIC IMPACT; FACTOR RECEPTOR-3; ADENOCARCINOMA; ANGIOGENESIS; MACROPHAGES;
D O I
10.1016/j.lungcan.2008.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lymph node metastasis is an essential determinant for stage and clinical management of non-small cell lung cancer (NSCLC). The vascular endothelial growth factors (VEGFs) and receptors (VEGFRs) are fundamental molecules in angiogenesis and lymphangiogenesis. We aimed to explore the correlations between nodal metastasis and the expression of VEGFs and VEGFRs in tumor cells and in tumor-related stroma. Patients and methods: Tumor tissue samples from 335 resected patients with stage I-IIIA NSCLC were obtained and tissue microarrays were constructed from duplicate cores of tumor cells and surrounding stromal tissue from each resected specimen. Immunohistochemistry was used to evaluate the expression of VEGF-A, VEGF-C, and VEGF-D and VEGFR-1, VEGFR-2 and VEGFR-3. Results: There were 232 NO and 103 N+ patients (76 N1, 27 N2). In multivariate analyses, low stromal VEGF-A expression (P=0.018) is associated with N+ status. In tumor cells, strong correlations exist between high VEGF-A expression (P=0.032) and N+ status, and high VEGFR-3 expression (P<0.001) and N2-status. Conclusion: The converse impact by stromal VEGF-A versus tumor cell VEGF-A expression on nodal metastasis may allude the importance of the tumor-stroma interaction when trying to understand lymphatic metastasis in NSCLC. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 31 条
  • [1] Targeting lymphangiogenesis to prevent tumour metastasis
    Achen, M. G.
    Mann, G. B.
    Stacker, S. A.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1355 - 1360
  • [2] Lymphangiogenesis in development and human disease
    Alitalo, K
    Tammela, T
    Petrova, TV
    [J]. NATURE, 2005, 438 (7070) : 946 - 953
  • [3] Molecular mechanisms of lymphangiogenesis in health and disease
    Alitalo, K
    Carmeliet, P
    [J]. CANCER CELL, 2002, 1 (03) : 219 - 227
  • [4] [Anonymous], 1999, HIST TYP LUNG PLEUR
  • [5] Clinical significance of vascular, endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
    Arinaga, M
    Noguchi, T
    Takeno, S
    Chujo, M
    Miura, T
    Uchida, Y
    [J]. CANCER, 2003, 97 (02) : 457 - 464
  • [6] Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis
    Björndahl, MA
    Cao, R
    Burton, JB
    Brakenhielm, E
    Religa, P
    Galter, D
    Wu, L
    Cao, YH
    [J]. CANCER RESEARCH, 2005, 65 (20) : 9261 - 9268
  • [7] Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
    Bremnes, RM
    Camps, C
    Sirera, R
    [J]. LUNG CANCER, 2006, 51 (02) : 143 - 158
  • [8] High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
    Bremnes, RM
    Veve, R
    Gabrielson, E
    Hirsch, FR
    Baron, A
    Bemis, L
    Gemmill, RM
    Drabkin, HA
    Franklin, WA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2417 - 2428
  • [9] Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer
    Chen, FS
    Takenaka, K
    Ogawa, E
    Yanagihara, K
    Otake, Y
    Wada, H
    Tanaka, F
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8548 - 8553
  • [10] Paradoxical roles of the immune system during cancer development
    de Visser, KE
    Eichten, A
    Coussens, LM
    [J]. NATURE REVIEWS CANCER, 2006, 6 (01) : 24 - 37